SUMMARY Treatment of 41 morbidly obese patients with a 3X34 mega joule diet has been compared with the same dietary regime together with an intragastric balloon. After eight weeks of closely supervised dietary regime a free floating silicone intragastric balloon with a capacity of 500 ml was inserted and the patient advised to adhere to the same diet for a further eight weeks. Thirty four patients completed the study. Forty eight per cent lost weight during the dietary period compared with 97 % during balloon treatment. The mean weight loss with diet alone was 1X9 (3) kg compared with 7X5 (4X 1) kg with the balloon (p<0.001). Apart from postinsertion vomiting, which resolved by 72 hours, there were no gastric complications associated wit...
The intragastric balloon is a safe procedure inducing weight loss in selected obese patients, especi...
PubMedID: 23404240Background: Most of the weight loss with the BioEnterics intragastric balloon (BIB...
Two consecutive and matched groups of morbidly obese patients, i.e. group (1) and (2) were selected ...
Objective: Obesity is a serious and chronic disease with genetic and environmental interference. Sev...
The Bioenterics Intragastric Balloon (BIB) is effective for weight loss. However, comparisons of its...
Introduction: intragastric balloons provide early satiety and thereby induce short-term weight loss....
Background: The intragastric balloon is widely used for weight reduction in obese patients, but resu...
Abstract Aim of this study is to compare the efficacy of BioEnterics Intragastric Balloon (BIB¨) fol...
Background Very few studies have reported results of the BioEnterics Intragastnic Balloon (BIB (R)) ...
Background. The intragastric balloon (IB) system has been designed to assist weight loss by partial...
BACKGROUND AND STUDY AIMS: To determine long-term outcome after treatment with an intragastric ballo...
PubMedID: 24557961Background/aims: The BioEnterics intragastric balloon has been considered an effec...
Background: Since 1998, we adopted in our clinical practice for treatment of obesity and morbid obes...
Aim: Bariatric surgery is a costly and invasive method with permanent effects and medications for tr...
Eating disorders are a group of conditions characterised by abnormal eating habits. Greater than 50 ...
The intragastric balloon is a safe procedure inducing weight loss in selected obese patients, especi...
PubMedID: 23404240Background: Most of the weight loss with the BioEnterics intragastric balloon (BIB...
Two consecutive and matched groups of morbidly obese patients, i.e. group (1) and (2) were selected ...
Objective: Obesity is a serious and chronic disease with genetic and environmental interference. Sev...
The Bioenterics Intragastric Balloon (BIB) is effective for weight loss. However, comparisons of its...
Introduction: intragastric balloons provide early satiety and thereby induce short-term weight loss....
Background: The intragastric balloon is widely used for weight reduction in obese patients, but resu...
Abstract Aim of this study is to compare the efficacy of BioEnterics Intragastric Balloon (BIB¨) fol...
Background Very few studies have reported results of the BioEnterics Intragastnic Balloon (BIB (R)) ...
Background. The intragastric balloon (IB) system has been designed to assist weight loss by partial...
BACKGROUND AND STUDY AIMS: To determine long-term outcome after treatment with an intragastric ballo...
PubMedID: 24557961Background/aims: The BioEnterics intragastric balloon has been considered an effec...
Background: Since 1998, we adopted in our clinical practice for treatment of obesity and morbid obes...
Aim: Bariatric surgery is a costly and invasive method with permanent effects and medications for tr...
Eating disorders are a group of conditions characterised by abnormal eating habits. Greater than 50 ...
The intragastric balloon is a safe procedure inducing weight loss in selected obese patients, especi...
PubMedID: 23404240Background: Most of the weight loss with the BioEnterics intragastric balloon (BIB...
Two consecutive and matched groups of morbidly obese patients, i.e. group (1) and (2) were selected ...